 1. Co-medication that may interfere with study results, e.g., immuno-suppressive agents other than corticosteroids. Steroid therapy for control of cerebral edema is allowed at the discretion of the Investigator. Subjects should be on a stable dose of steroids for at least 1 week prior to first dose of MRZ. 